Jeffrey J. Letourneau

The Discovery of Orally Active Triaminotriazine Aniline Amides as Inhibitors of p38 MAP Kinase

Katerina Leftheris, Gulzar Ahmed, Ran Chan et al. · Journal of Medicinal Chemistry · 2004 · 50 citations · Full text

P38 Map Kinase, Triaminotriazine Aniline, Pharmacotherapy +19

2-Benzimidazolyl-9-(chroman-4-yl)-purinone derivatives as JAK3 inhibitors

Andrew G. Cole, Adolph C. Bohnstedt, Vidyadhar M. Paradkar et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 18 citations · Full text

Medicinal Chemistry, Biochemistry, Medicine +8

Treatment of Clostridium difficile Infection with a Small-Molecule Inhibitor of Toxin UDP-Glucose Hydrolysis Activity

Ilana L. Stroke, Jeffrey J. Letourneau, Teresa E. Miller et al. · Antimicrobial Agents and Chemotherapy · 2018 · 17 citations · Full text

Recurrent Infections, Antibiotic Adjuvant, Immunology +18

A novel and convenient synthesis of 5-aryl-4-bromo-3-carboxyisoxazoles: useful intermediates for the solid-phase synthesis of 4,5-diarylisoxazoles

Jeffrey J. Letourneau, Christopher M. Riviello, Michael Ohlmeyer · Tetrahedron Letters · 2007 · 12 citations

Solid-phase Synthesis, Diversity-oriented Synthesis, Organic Chemistry +5